+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DNA Synthesizer Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895185
The global DNA synthesizer market size was valued at USD 261.1 million in 2023, driven by the increasing demand for efficient DNA synthesizers across the globe. The market size is anticipated to grow at a CAGR of 14.4% during the forecast period of 2024-2032 to achieve a value of USD 877.7 million by 2032.

DNA Synthesizer: Introduction

A DNA synthesizer is a laboratory instrument used in molecular biology to create artificial sequences of DNA. It assembles nucleotides (A, T, C, G) in a specific order, allowing for the custom synthesis of DNA strands. This technology is crucial in genetic research, diagnostics, and biotechnology, enabling the production of tailored DNA sequences for various applications, such as gene cloning, protein expression, and the study of genetic diseases.

Key Trends in the Global DNA Synthesizer Market

In recent years, the global DNA synthesizer market has witnessed significant trends that are shaping the landscape of genetic research and molecular biology. Firstly, there has been a notable surge in demand for high-throughput DNA synthesizers, driven by the growing need for large-scale genomic studies and personalized medicine initiatives. This has led to the development of advanced synthesizers capable of efficiently producing long sequences of DNA with increased speed and accuracy.

Another prominent trend is the integration of automation and artificial intelligence (AI) in DNA synthesis processes. Automation streamlines workflows, reducing human error and enhancing overall efficiency. AI applications contribute to the optimization of DNA sequence design, improving the predictability and reliability of synthesis outcomes.

Furthermore, the market has seen a rise in the adoption of benchtop DNA synthesizers, catering to the needs of smaller research laboratories and academic institutions. These compact synthesizers offer cost-effective solutions without compromising performance, making DNA synthesis more accessible.

Collaborations and partnerships between key market players and research institutions have become common, fostering innovation and technological advancements in the field. This collaborative approach has accelerated the development of novel techniques and methodologies for DNA synthesis.

Lastly, the market has been influenced by a heightened focus on sustainable practices, with an emphasis on eco-friendly reagents and synthesis processes. This reflects the industry's commitment to reducing its environmental footprint.

Global DNA Synthesizer Market Segmentation

Market Breakup by Type

  • Benchtop DNA Synthesizers
  • Large-scale DNA Synthesizers

Market Breakup by Application

  • Research and Development
  • Academic
  • Industrial
  • Diagnosis
  • Therapeutics

Market Breakup by End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global DNA Synthesizer Market Overview

North America has led the global DNA synthesizer market due to the region's advanced biotechnology and life sciences sector. The United States houses major biotech companies, research institutions, and pharmaceutical firms at the forefront of genetic research. Robust investment in research and development, a well-established infrastructure, and a high concentration of biotech innovation contribute to North America's dominant position in the DNA synthesizer market.

European countries, including the United Kingdom, Germany, and France, have a significant presence in the DNA synthesizer market. These nations boast advanced healthcare systems, renowned research institutions, and a strong emphasis on genomics research and molecular biology.

The Asia Pacific region is projected to experience substantial growth in the DNA synthesizer market. Factors contributing to this growth include a rising focus on genomics research, increasing investments in biotechnology, and the expanding pharmaceutical and healthcare sectors. Countries like China, Japan, and India are at the forefront of this growth, with an increasing demand for DNA synthesizers in research and development activities.

Global DNA Synthesizer Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in the market are as follows:

  • LGC Biosearch Technologies
  • Bioneer Corporation
  • Thermo Fisher Scientific, Inc.
  • IBA GmbH
  • Twist Bioscience
  • Eton Bioscience
  • Quintara Biosciences
  • Eurofins Scientific
  • Integrated DNA Technologies, Inc
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global DNA Synthesizer Market Overview
3.1 Global DNA Synthesizer Market Historical Value (2017-2023)
3.2 Global DNA Synthesizer Market Forecast Value (2024-2032)
4 Global DNA Synthesizer Market Landscape
4.1 DNA Synthesizer: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 DNA Synthesizer: Product Landscape
4.2.1 Analysis by Application
4.2.2 Analysis by Type
4.2.3 Analysis by End User
5 Global DNA Synthesizer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global DNA Synthesizer Market Segmentation
6.1 Global DNA Synthesizer Market by Type
6.1.1 Market Overview
6.1.2 Benchtop DNA Synthesizers
6.1.3 Large-scale DNA Synthesizers
6.2 Global DNA Synthesizer Market by Application
6.2.1 Market Overview
6.2.2 Research and Development
6.2.3 Academic
6.2.4 Industrial
6.2.5 Diagnosis
6.2.6 Therapeutics
6.3 Global DNA Synthesizer Market by End User
6.3.1 Market Overview
6.3.2 Biopharmaceutical Companies
6.3.3 Academic and Research Institutes
6.3.4 Contract Research Organizations
6.4 Global DNA Synthesizer Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America DNA Synthesizer Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe DNA Synthesizer Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific DNA Synthesizer Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America DNA Synthesizer Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa DNA Synthesizer Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 LGC Biosearch Technologies
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bioneer Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Thermo Fisher Scientific, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 IBA GmbH
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Twist Bioscience
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Eton Bioscience
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Quintara Biosciences
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Eurofins Scientific
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Integrated DNA Technologies, Inc
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Integrated DxNA Technologies, Inc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket

Companies Mentioned

  • LGC Biosearch Technologies
  • Bioneer Corporation
  • Thermo Fisher Scientific Inc.
  • IBA GmbH
  • Twist Bioscience
  • Eton Bioscience
  • Quintara Biosciences
  • Eurofins Scientific
  • Integrated DNA Technologies Inc
  • Integrated DxNA Technologies Inc

Methodology

Loading
LOADING...